NCT00409708View on ClinicalTrials.gov

Effects of Methylphenidate on Cellular Abnormalities in Children With Attention Deficit Hyperactivity Disorder (ADHD)

PHASE2CompletedINTERVENTIONAL

Enrollment

142

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

March 31, 2008

Conditions

Attention Deficit Hyperactivity Disorder

Interventions

DRUG

Extended Release Methylphenidate (Ritalin LA ) plus Behavior Therapy

BEHAVIORAL

Behavior Therapy

Trial Locations (1)

77007

Novartis Pharmaceuticals Investigational site, Houston

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Novartis

INDUSTRY